To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ About The Study: In hospitalized adults, daily procalcitonin -guided protocol reduced antibiotic duration safely compared with standard care, but daily C-reactive protein -guided protocol does not. All-cause mortality for C-reactive protein was inconclusive.
Corresponding Author: To contact the corresponding author, Paul Dark, MD, PhD, email adaptsepsistrial@warwick.ac.uk .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.26458)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: This study is being presented at the Critical Care Reviews Down Under meeting.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.26458?guestAccessKey=bececbf0-6542-489f-88dd-1e444426bd6a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120924
JAMA